Discovery & Development

Sitting down with… Matthew Todd, Chair of Drug Discovery at UCL and founder of the Open Source Pharma movement.

Explore TOSOH’s expertise across all stages of therapeutic antibody development.

How is pharma using advances in technology to its benefit?

A cell-free biologic could act as platform therapeutic for a variety of serious diseases.

What needs to change to improve our odds in the fight against AMR?

Researchers seek a way to inactivate CAR-T cells in case of adverse effects.

We announce a new Special Series of articles devoted to advanced medicine.

What type of dosage form would a patient prefer to take? Additive manufacturing provides the ultimate flexibility.

Why virtual and augmented reality technologies are the future of workforce training.

What’s on the horizon for the field of nanomedicine?